Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05472844

The Cohort Study of Pediatric Cataract

This retrospective-prospective bidirectional cohort study aims to observe ocular parameter changes, different surgical/vision recovery strategies and postoperative adverse effects among young children with cataract. The influence on psychology and cognitive function will be taken into consideration as well.

Recruiting

Interested in participating?

Request Info

Key information

Age range

Up to 18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Zhongshan Ophthalmic Center

Guangzhou, Guangdong, 510060, China

Location status: Recruiting

Location contact

Yizhi Liu, PhD

PRINCIPAL_INVESTIGATOR

Zhenzhen Liu, PhD

CONTACT

[email protected]

+020 66618932

About this study

Pediatric cataract, one of the leading causes of childhood blindness globally, is complex and of great difficulty in treatment. Pediatric patients with cataract (congenital, traumatic or complicated) are enrolled. In this study, investigators will compare ocular parameter changes, different surgical/vision timing or recovery strategies and adverse effects among young children (age < 18 yo)before and after cataract surgery. The influence on psychology and cognitive function will be taken into consideration as well. The whole blood samples of participants and parents are collected and retained in our biobank for gene sequencing, hoping to explore the genetic factors in association with pathogenesis. For children received cataract surgery, samples of partial anterior capsular tissue and 1 ml aqueous humor were collected during operation for further analysis. Multimodal artificial intelligence analyses are performed to establish accurate diagnosis/treatment scheme and disease prediction model.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • aged < 18 yo at the 1st visit unilateral or bilateral cataract agree to participant in this study and sign the informed consent

Exclusion criteria

  • adults

Treatment and study plan

Primary outcomes

  1. Best-corrected visual acuity changes

    Time frame: Baseline and through study completion, an average of 1 year

    Best-corrected visual acuity changes are measured by visual acuity charts (Teller/Lea symbol/ETDRS chart) every 1 year at scheduled time

  2. Intraocular pressure changes

    Time frame: Baseline and through study completion, an average of 1 year

    Intraocular pressures are measured by NCT machine

  3. Refractive power changes

    Time frame: Baseline and through study completion, an average of 1 year

    Refractive power are measured at baseline and every visit at least every 1 year

  4. Ocular biological measurements changes

    Time frame: Baseline and through study completion, an average of 1 year

    Ocular biological measurements including axial length, corneal keratometry, anterior chamber angle/depth, corneal endothelial cell number and appearance

  5. Incidence changes of postoperative complications

    Time frame: Baseline and through study completion, an average of 1 year

    Incidence of postoperative complications, such as glaucoma-related adverse, myopic shift, strabismus and anisometropia and so on

Secondary outcomes

  1. Other factors changes

    Time frame: Baseline and through study completion, an average of 1 year

    Sleep, depression, cognitive function are measured by questionnaires. Self-Rating Scale of Sleep: minimum value-1 point, maximum value-50, and higher scores mean worse outcome. Hamilton Depression Scale: <7 points-normal, and higher scores mean worse outcome. Loewenstein Cognitive Assessment: for every question, minimum 1 point, and maximum 4 points. Higher scores mean worse outcomes.

  2. BMI changes

    Time frame: Baseline and through study completion, an average of 1 year

    BMI is measured by technicians in every visit

  3. Blood pressure changes

    Time frame: Baseline and through study completion, an average of 1 year

    Diastolic and systolic blood pressure are measured by technicians in every visit

  4. Stereopsis changes

    Time frame: Baseline and through study completion, an average of 1 year

    Stereopsis is measured by Randot Stereotest

  5. Optical coherence tomography (OCT) changes

    Time frame: Baseline and through study completion, an average of 1 year

    Retinal thickness is measured and analyzed by OCT

Study contacts

Contact information is provided by the study sponsor or research team.

Zhenzhen Liu, PhD

CONTACT

[email protected]

+020 66618932

Sponsors and collaborators

Lead sponsor

Zhongshan Ophthalmic Center, Sun Yat-sen University

Other

Registry information

Important dates

Study start
2022
Primary completion
2032
Study completion
2032
First posted
Jul 25, 2022
Registry last updated
Sep 27, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.